These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37920706)

  • 1. My-Lupus: A case of anti-transcriptional intermediary factor 1-gamma antibody-positive  dermatomyositis overlapping with discoid lupus erythematosus in an adult patient.
    Toker M; Zhu TR; Srivastava P; Amin B; Lee J; Wang S; Wu B
    JAAD Case Rep; 2023 Nov; 41():90-92. PubMed ID: 37920706
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical significance of serum levels of anti-transcriptional intermediary factor 1-γ antibody in patients with dermatomyositis.
    Ikeda N; Yamaguchi Y; Kanaoka M; Ototake Y; Akita A; Watanabe T; Aihara M
    J Dermatol; 2020 May; 47(5):490-496. PubMed ID: 32103537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.
    Sato Y; Tanino Y; Nikaido T; Togawa R; Kawamata T; Watanabe N; Sato R; Yamada R; Onuma T; Tomita H; Saito M; Rikimaru M; Morimoto J; Suzuki Y; Minemura H; Saito J; Kanazawa K; Yamada S; Hashimoto Y; Shibata Y
    BMC Pulm Med; 2022 May; 22(1):191. PubMed ID: 35549684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Mixed Connective Tissue Disease That Transformed Into Systemic Lupus Erythematosus After a Long Clinical Course.
    Sato F; Sato M; Yamano T; Yamaguchi K; Miyake T
    Cureus; 2023 Apr; 15(4):e38201. PubMed ID: 37252562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of anti-transcriptional intermediary factor 1-γ antibody in patients with dermatomyositis: a monocentric cross-sectional study.
    Yang H; Yan T; Zhang X; Sun W; Liu L; Du Y; Xue J
    Clin Rheumatol; 2022 Aug; 41(8):2439-2448. PubMed ID: 35422109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-transcriptional intermediary factor 1-γ antibody as a biomarker in patients with dermatomyositis.
    Shimizu K; Kobayashi T; Kano M; Hamaguchi Y; Takehara K; Matsushita T
    J Dermatol; 2020 Jan; 47(1):64-68. PubMed ID: 31638280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of distinct cytokine/chemokine profiles in dermatomyositis with anti-transcriptional intermediary factor 1-γ antibody.
    Zhao Q; Chen Y; Diao L; Zhang S; Wu D; Xue F; Xia Q; Li H; Zheng J; Cao H
    Rheumatology (Oxford); 2022 May; 61(5):2176-2184. PubMed ID: 34508564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlap syndrome involving anti-OJ antibody-positive polymyositis, systemic lupus erythematosus and Sjögren's syndrome: A case report and literature review.
    Mizuhashi Y; Hirata S; Sakata K; Miyagawa E; Iwakura M; Murai M; Sasai T; Matsuoka M
    Mod Rheumatol Case Rep; 2023 Jun; 7(2):399-403. PubMed ID: 36424872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of anti-transcriptional intermediary factor 1 gamma autoantibody-positive dermatomyositis patients in Singapore.
    Chua CG; Low JZ; Lim WY; Manghani M
    Ann Acad Med Singap; 2022 Dec; 51(12):755-765. PubMed ID: 36592144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus?
    Merola JF; Chang CA; Sanchez MR; Prystowsky SD
    J Drugs Dermatol; 2011 Dec; 10(12):1413-20. PubMed ID: 22134565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-MDA5 Antibody Dermatomyositis Overlap with Systemic Lupus Erythematosus: A Case Report and Review of the Literature.
    Milam EC; Futran J; Franks AG
    Open Rheumatol J; 2016; 10():122-128. PubMed ID: 28077979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-γ, and Point Mutation in the Transcription Intermediary Factor 1-γ Coding Gene: A Case Report.
    Arnon J; Elia A; Nevo Y; Lossos A; Nechushtan H
    JTO Clin Res Rep; 2021 Sep; 2(9):100217. PubMed ID: 34590056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of anti-transcriptional intermediary factor 1-γ autoantibody associated with the clinical, pathological characteristics and outcomes of patients with dermatomyositis.
    Zhang L; Yang H; Yang H; Liu H; Tian X; Jiang W; Peng Q; Wang G; Lu X
    Semin Arthritis Rheum; 2022 Aug; 55():152011. PubMed ID: 35489170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset systemic lupus erythematosus associated with inverse discoid lupus erythematosus on the buttock.
    Kelly BG; Forbes BR; Thiede RM
    JAAD Case Rep; 2022 Jun; 24():115-117. PubMed ID: 35662853
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.
    Muro Y; Ishikawa A; Sugiura K; Akiyama M
    Rheumatology (Oxford); 2012 Aug; 51(8):1508-13. PubMed ID: 22539482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiles of antinuclear antibodies in systemic rheumatic diseases.
    Notman DD; Kurata N; Tan EM
    Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic and clinical features of patients with discoid lupus erythematosus: relationship of antibodies to single-stranded deoxyribonucleic acid and of other antinuclear antibody subsets to clinical manifestations.
    Callen JP; Fowler JF; Kulick KB
    J Am Acad Dermatol; 1985 Nov; 13(5 Pt 1):748-55. PubMed ID: 3878371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of patients with systemic lupus erythematosus and discoid lesions.
    Skare TL; Stadler B; Weingraber E; De Paula DF
    An Bras Dermatol; 2013; 88(5):755-8. PubMed ID: 24173181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis induced by nivolumab for lung adenocarcinoma: A case report.
    Osaki M; Tachikawa R; Ohira J; Hara S; Tomii K
    Invest New Drugs; 2021 Feb; 39(1):251-255. PubMed ID: 32651759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of discoid lupus erythematosus to mixed connective tissue disease.
    Gilliam JN; Prystowsky SD
    J Rheumatol; 1977; 4(2):165-9. PubMed ID: 881692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.